$2.33
-0.92-28.24%
Last update: Oct 26, 12:02 PM
Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, News & History
NAUTNASDAQ
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech...
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Nautilus Biotechnology has a consensus price target of $3.25.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $2.325 last updated October 26, 2026 at 12:02 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the...
